Similar Articles
2231 Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma
2232 A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma
2233 Natural history of hepatitis-related hepatocellular carcinoma
2234 Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
2235 Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review
2236 Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
2237 Is human hepatocellular carcinoma a hormone-responsive tumor?
2238 Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
2239 Activins and activin antagonists in hepatocellular carcinoma
2240 Current role of ultrasound for the management of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA